When you first start Wegovy, youll be prescribed the lowest dose, which will increase every 4 weeks until you reach the maintenance dose of 7.2 mg per week or whichever dose is most suited to you
The specific thresholds that should prompt dose reduction or discontinuation include: ALT or AST elevation exceeding 3 times the patient's baseline value, new or worsening coagulopathy (INR increase of 0.5 or more from baseline), albumin decline below 2.5 g/dL, or new clinical signs of hepatic decompensation such as worsening ascites, encephalopathy, or jaundice [5]
Researchers should note that despite ipamorelins favorable safety profile, peptide administration in general is associated with injection site pain, lightheadedness, nausea, and even flu-like symptoms in subjects
This is important because energy production isnt just about caloriesits about how efficiently your body uses them
See my options Entities covered Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages